MicroRNAs(miRNAs) are a newly discovered class of small noncoding RNAs that rcgulate gene expression by translational repression or mRNA degradation.It has become evident that miRNAs are involved in many important biological processes,including tissue differentiation and development,showing a tissue specificity and development-stage specificity.In the other hand,miRNAs play critical roles in neovascularization and a variety of pathophysiological processes,such as pathological angiogenesis,oxidative stress response,immune response and inflammation.Currently,miRNAs of the retina,lens and cornea have been established,and they would be potential therapeutic targets in the eye diseases.Here,the distribution of miRNAs in the eye and their role in ocular diseases were summarized.

Rectal cancer is one of the common malignant tumors in China,and the incidence rate is rising year by year.Comprehensive treatment based on surgical operation is the major treatment of low rectal cancer.The treatment concept requires not only radical resection of tumor,but also preservation of the anal and urogenital function,to improve the quality of patients' life.By improving the accuracy of preoperative staging of rectal cancer,neoadjuvant therapy,and following the principle of total mesorectal excision,patients can benefit in terms of increased resection rate,decreased operation complication incidence,increased sphincter preservation,decreased local recurrence and increased overall survival rate.With the development of medical technology,minimally invasive surgery of low rectal cancer has been developed rapidly.In this paper,new progress in the surgical treatment of low rectal cancer will be reviewed.

Objective To observe the therapeutic effect of Chinese herbal and western medicines(CHM & WM)combined with acupoint pulse-laser stimulation(APLS)for calculus of upper urinary tract.Methods Sixty cases of calculus of upper urinary tract were allocated to the treatment group(Group A,n=36)and the control group (Group B,n=24).Group A was treated with CHM & WM combined with APLS and Group B with CHM alone.Results The therapeutic effect rate was 94.4% and 75.0% in Group A and Group B respectively (P

Alzheimer's disease(AD) is one of the most common causes of mental deterioration in elderly individuals, accounting for around 45~60% of the overall cases of dementia over 65 years of age. Although there is presently no "cure" for AD, a large number of potential therapeutic interventions have emerged to correct cholinergic dysfunctions. Currently, cholinergic therapy, particularly cholinesterase inhibition, represents the most realistic approach to the symptomatic treatment of AD. Modest efficacy for mild to moderate AD has been shown in well-designed clinical trials for tacrine, donepezil, rivastigmine, and galantimine. Among other treatment options, estrogen replacement therapy in postmenopausal women is under active investigation, but recent studies showed somewhat disappointing results. Epidemiological and clinical data suggest that nonsteroidal anti-inflammatory drugs are beneficial in the treatment and prevention of AD. But prednisone and COX-2 inhibitor, celecoxib showed no clinical benefit in recent studies. Alpha-tocopherol and gingko biloba showed some beneficial effect in delaying the progression of AD and enhancing cognitive functions. Immunization with beta amyloid peptide was considered to be the only method to prevent and halt disease progression in patients with AD. Recently, phase II clinical trial using synthetic beta amyloid peptide (AN-1792) was discontinued because some patients showed neuro-inflammation which may be caused by autoimmune responses.
Aged ; alpha-Tocopherol ; Alzheimer Disease* ; Amyloid ; Autoimmunity ; Celecoxib ; Cholinesterases ; Cognition ; Dementia ; Disease Progression ; Estrogen Replacement Therapy ; Female ; Ginkgo biloba ; Humans ; Immunization ; Methods ; Prednisone ; Rivastigmine ; Tacrine

Animals ; Hepacivirus ; genetics ; Hepatitis C ; immunology ; prevention & control ; therapy ; virology ; Humans ; Mutation ; Viral Hepatitis Vaccines ; immunology

OBJECTIVE:To prepare Shangyangyu gel and establish a standard for its quality.METHODS:Shangyangyu gel was prepared using carbamer 940 as matrix.Its content was identified by spectrophotography,with the wavelength set at 516nm,and its other compositions were determined by TLC.RESULTS:The concentration of L-shikonin had good linear correlation with absorbance in the range of 8.048～ 40.24? g? mL-1(r=0.999 8).The average recovery rate was 99.45%(RSD=1.13%).CONCLUSION:This method for preparation of Shangyangyu gel was simple in technique and the standard can be used for the quality control.

OBJECTIVE To observe the inhibition of the expression of HIF-1? and VEGF induced by LPS in primary human nasal epithelial cell (HNEC) by dexamethasone. METHODS Epithelial cells of nasal polyps (NP) and inferior turbinate (IT) were cultured without serum under stimulus of LPS 100 ng/ml, IL-1? 20 ng/ml, LPS 100 ng/ml +dexamethasone 13 ng/ml and IL-1? 20 ng/ml+ dexamethasone 13 ng/ml for 3h, 6h and 9h respectively. The expression of HIF-1?, VEGF protein and mRNA derived from epithelial cells was detected by immunocytochemistry and situ hybridization. RESULTS ①The expression of HIF-1? and VEGF increased under the stimulus of LPS and IL-1? with the increasing of time and concentration, especially under LPS 100 ng/ml for 6h (P

Objective To observe weight and serum leptin changes in epileptic women who taking valproate or topiramate. Method All 40 epileptic women were treated with valproate or topiramate. Weight and body mass index and serum leptin were measured before and after three months treatment. Result Nine of 20 patients taking valproate gained weight (≥4 kg), and their serum leptin concentration was increased as well [(13.2?3.6) ng/ml vs (7.4?3.0)ng/ml, P

AIM: By introducing the thinking and experience of professor Deng Tietao to treat myasthenia gravis, to improve the therapeutic effect and prognosis.benefiting vital qi had been the main line throughout the whole process of phasized that while we grasp spleen-asthenia, we must give consideration to other organs at the same time, regulate and treat the patient with multistrengthening muscle and increasing strength (radix astragali, radix codonopsis pilosulae, rhizoma atractylodis macrocephalae, rhizoma cimicifugae, pericarpium citri reticulatae, radix fici simplicissimae, etc.), the disease had been treated with different dosage of drugs according to the py for one or two years, even though the symptoms had disappeared completely.RESULTS: Because of grasping the root cause, therapy with multi-means and modified prescription according to the varied symptoms, it had a satisfactory effect. An excellent therapeutic effect had been obtained with the decoction for strengthening muscle and increasing strength, which is created by Deng himself.CONCLUSION: Deng's theory holds that myasthenia gravis is mainly due to spleen-asthenia, and related to other four organs (with a predominance of kidney), and the therapy should be strengthening the spleen-qi, so the prescription was selected for strengthening muscle and increasing strength (which is created by Deng himself), with radix astragali being in a lager quantity. Moreover, he paid more attention to psychological therapy and dietary regulation. The Deng's theory is of considerable clinical significance in guiding treatment of myasthenia gravis.

Objective To study the effects of zinc-metallothionein (ZnMT) on the cadmium-induced oxidative damage of liver and kidney in mice. Methods The model of laboratory animal was established by 14 d-cadmium exposure to Kunming mice. Then the cadmium-poisoning mice were grouped as Cd-ZnMT group and Cd-ZnSO4 group and perfused orally by solution of ZnMT and ZnSO4 for 14 days respectively. The morphological changes of liver and kidney were observed by electron microscope. The contents of malonydiadehyde (MDA), the activities of superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) in supernatant fluid of liver and kidney were determined. Results The decreases of the contents of MDA, the increases of the activities of SOD and GSH-Px in liver and kidney of mice in Cd-ZnMT and Cd-ZnSO4-exposure group were observed compared with those in cadmium-exposure group, the dose-effect relationships were also found. The increases of the activities of SOD and GSH-Px, the decrease of contents of MDA of liver and kidney, were found in Cd-ZnMT-exposure group compared with those of Cd-ZnSO4-exposure group, but without statistical significances. The morphological damages of liver and kidney observed by electron microscope in mice of cadmium-exposure group were more serious than those in mice treated with solution of ZnMT and ZnSO4 after cadmium exposure. Conclusion ZnMT could repair the lipid peroxidative damages in liver and kidney in mice induced by exposure to cadmium in a certain degree.